SOGHIN clinical practice guidelines for hepatocellular carcinoma

Abstract

HCC accounts for over 90% of primary liver cancers and 7% of all cancers from all sites worldwide. In Nigeria, HCC develops at a younger age compared to the developed world and co-exists with liver cirrhosis in about 80% of cases. The prognosis is dismal because the majority of HCC patients present with advanced disease, when only symptomatic treatment could be given. These Clinical Practice Guidelines contains extensive review of relevant data and provide practitioners in this resource-limited setting with the necessary information that would help detect liver cancer at early stages, when there is a possibility of cure, as well as assist in selecting patients, whose survival may be significantly prolonged, for treatment.